715 related articles for article (PubMed ID: 19469474)
21. Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives.
Ranise A; Spallarossa A; Cesarini S; Bondavalli F; Schenone S; Bruno O; Menozzi G; Fossa P; Mosti L; La Colla M; Sanna G; Murreddu M; Collu G; Busonera B; Marongiu ME; Pani A; La Colla P; Loddo R
J Med Chem; 2005 Jun; 48(11):3858-73. PubMed ID: 15916438
[TBL] [Abstract][Full Text] [Related]
22. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
[TBL] [Abstract][Full Text] [Related]
24. Parallel one-pot synthesis and structure-activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Cesarini S; Spallarossa A; Ranise A; Schenone S; Bruno O; La Colla P; Casula L; Collu G; Sanna G; Loddo R
Bioorg Med Chem; 2008 Jun; 16(12):6353-63. PubMed ID: 18502646
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and anti-HIV-1 activity evaluation of 5-alkyl-2-alkylthio-6-(arylcarbonyl or alpha-cyanoarylmethyl)-3,4-dihydropyrimidin-4(3H)-ones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Ji L; Chen FE; De Clercq E; Balzarini J; Pannecouque C
J Med Chem; 2007 Apr; 50(8):1778-86. PubMed ID: 17381078
[TBL] [Abstract][Full Text] [Related]
26. Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.
Chan JH; Freeman GA; Tidwell JH; Romines KR; Schaller LT; Cowan JR; Gonzales SS; Lowell GS; Andrews CW; Reynolds DJ; St Clair M; Hazen RJ; Ferris RG; Creech KL; Roberts GB; Short SA; Weaver K; Koszalka GW; Boone LR
J Med Chem; 2004 Feb; 47(5):1175-82. PubMed ID: 14971897
[TBL] [Abstract][Full Text] [Related]
27. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
[TBL] [Abstract][Full Text] [Related]
28. Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays.
Chen W; Zhan P; Rai D; De Clercq E; Pannecouque C; Balzarini J; Zhou Z; Liu H; Liu X
Bioorg Med Chem; 2014 Mar; 22(6):1863-72. PubMed ID: 24581546
[TBL] [Abstract][Full Text] [Related]
29. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 13: synthesis of fluorine-containing diaryltriazine derivatives for in vitro anti-HIV evaluation against wild-type strain.
Xiong YZ; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Chem Biodivers; 2009 Apr; 6(4):561-8. PubMed ID: 19353537
[TBL] [Abstract][Full Text] [Related]
30. The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors.
Lu X; Chen Y; Guo Y; Liu Z; Shi Y; Xu Y; Wang X; Zhang Z; Liu J
Bioorg Med Chem; 2007 Dec; 15(23):7399-407. PubMed ID: 17870545
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
Chen X; Zhan P; Liu X; Cheng Z; Meng C; Shao S; Pannecouque C; De Clercq E; Liu X
Bioorg Med Chem; 2012 Jun; 20(12):3856-64. PubMed ID: 22591854
[TBL] [Abstract][Full Text] [Related]
32. Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus.
Piscitelli F; Coluccia A; Brancale A; La Regina G; Sansone A; Giordano C; Balzarini J; Maga G; Zanoli S; Samuele A; Cirilli R; La Torre F; Lavecchia A; Novellino E; Silvestri R
J Med Chem; 2009 Apr; 52(7):1922-34. PubMed ID: 19281225
[TBL] [Abstract][Full Text] [Related]
33. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity.
Xiong YZ; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Eur J Med Chem; 2008 Jun; 43(6):1230-6. PubMed ID: 17869386
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of pyridone inhibitors of non-nucleoside reverse transcriptase.
Gomez R; Jolly S; Williams T; Tucker T; Tynebor R; Vacca J; McGaughey G; Lai MT; Felock P; Munshi V; DeStefano D; Touch S; Miller M; Yan Y; Sanchez R; Liang Y; Paton B; Wan BL; Anthony N
Bioorg Med Chem Lett; 2011 Dec; 21(24):7344-50. PubMed ID: 22071300
[TBL] [Abstract][Full Text] [Related]
35. 5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3, 4-dihydropyrimidin-4(3H)-ones: novel potent and selective dihydro-alkoxy-benzyl-oxopyrimidine derivatives.
Mai A; Artico M; Sbardella G; Massa S; Novellino E; Greco G; Loi AG; Tramontano E; Marongiu ME; La Colla P
J Med Chem; 1999 Feb; 42(4):619-27. PubMed ID: 10052969
[TBL] [Abstract][Full Text] [Related]
36. Novel diarylpyridinones, diarylpyridazinones and diarylphthalazinones as potential HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs).
Venkatraj M; Ariën KK; Heeres J; Dirié B; Joossens J; Van Goethem S; Van der Veken P; Michiels J; Vande Velde CM; Vanham G; Lewi PJ; Augustyns K
Bioorg Med Chem; 2011 Oct; 19(20):5924-34. PubMed ID: 21930388
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological properties of novel 2-aminopyrimidin-4(3H)-ones highly potent against HIV-1 mutant strains.
Mai A; Artico M; Rotili D; Tarantino D; Clotet-Codina I; Armand-Ugón M; Ragno R; Simeoni S; Sbardella G; Nawrozkij MB; Samuele A; Maga G; Esté JA
J Med Chem; 2007 Nov; 50(22):5412-24. PubMed ID: 17910429
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of C-5 methyl substituted 4-arylthio and 4-aryloxy-3-Iodopyridin-2(1H)-one type anti-HIV agents.
Guillemont J; Benjahad A; Oumouch S; Decrane L; Palandjian P; Vernier D; Queguiner L; Andries K; de Béthune MP; Hertogs K; Grierson DS; Nguyen CH
J Med Chem; 2009 Dec; 52(23):7473-87. PubMed ID: 19645483
[TBL] [Abstract][Full Text] [Related]
39. Improving the antiviral efficacy and selectivity of HIV-1 reverse transcriptase inhibitor TSAO-T by the introduction of functional groups at the N-3 position.
Bonache MC; Chamorro C; Velázquez S; De Clercq E; Balzarini J; Barrios FR; Gago F; Camarasa MJ; San-Félix A
J Med Chem; 2005 Oct; 48(21):6653-60. PubMed ID: 16220981
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitors.
Mugnaini C; Manetti F; Esté JA; Clotet-Codina I; Maga G; Cancio R; Botta M; Corelli F
Bioorg Med Chem Lett; 2006 Jul; 16(13):3541-4. PubMed ID: 16621553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
